Diabetes Mellitus Is Associated With the Presence of Metastatic Spread at Disease Presentation in Hepatocellular Carcinoma
- 16 October 2012
- journal article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 30 (10) , 698-702
Abstract
Purpose: Diabetes mellitus (DM) is identified as a negative prognostic indicator in hepatocellular carcinoma (HCC). Methods: A retrospective review of HCC patients was conducted to assess the effect of DM on clinical variables. Results: Ninety-seven of 265 (34%) patients had DM at the time of diagnosis. Distant metastasis was found in 33% (30/91) of patients with DM compared with only 9.7% (17/174) of those without DM (OR: 4.5, 95% CI: 2.3–8.8, p < .0001). This difference remained significant when adjusting for other clinical variables (OR: 10.0, 95% CI: 3.9–25.7, p < .0001). Conclusions: DM is associated with the presence of metastatic disease among a single institution cohort of HCC patients.Keywords
This publication has 31 references indexed in Scilit:
- Mortality in nonalcoholic fatty liver disease: Clues from the cremona studyHepatology, 2011
- Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatmentNature Reviews Endocrinology, 2011
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005Journal of Clinical Oncology, 2009
- Type 2 diabetes and hepatocellular carcinomaHepatology, 2006
- Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control studyGut, 2005
- A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decadesProceedings of the National Academy of Sciences, 2002
- Clinical implications of hepatogenous diabetes in liver cirrhosisJournal of Gastroenterology and Hepatology, 2002
- The role of diabetes in hepatocellular carcinoma: a case-control study among United States veteransAmerican Journal of Gastroenterology, 2001
- Rising Incidence of Hepatocellular Carcinoma in the United StatesNew England Journal of Medicine, 1999
- Excess Risk of Primary Liver Cancer in Patients With Diabetes MellitusJNCI: Journal of the National Cancer Institute, 1996